These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34049245)

  • 1. Kinetics of the neutralising antibody response in patients with hand, foot, and mouth disease caused by EV-A71: A longitudinal cohort study in Zhengzhou during 2017-2019.
    Qiu Q; Zhou J; Cheng Y; Zhou Y; Liang L; Cui P; Xue Y; Wang L; Wang K; Wang H; Li P; Chen J; Li Y; Turtle L; Yu H
    EBioMedicine; 2021 Jun; 68():103398. PubMed ID: 34049245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Neutralizing Antibody Response Kinetics in Patients with Hand, Foot, and Mouth Disease Caused by Coxsackievirus A16 or Enterovirus A71: A Longitudinal Cohort Study of Chinese Children, 2017-2019.
    Zhou Y; Zhou J; Yang J; Qiu Q; Wang L; Yang J; Li Y; Liang L; Cui P; Cheng Y; Zheng W; Shi H; Gong H; Wang K; Zhou C; Chu JJH; Yu H
    J Immunol; 2022 Jul; 209(2):280-287. PubMed ID: 35777850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother-neonate cohort study.
    Wei X; Yang J; Gao L; Wang L; Liao Q; Qiu Q; Luo K; Yu S; Zhou Y; Liu F; Chen Q; Zhang J; Dai B; Yang H; Zhou J; Xing W; Chen X; He M; Ren L; Guo J; Luo L; Wu P; Chen Z; van Doorn HR; Cauchemez S; Cowling BJ; Yu H
    Lancet Infect Dis; 2021 Mar; 21(3):418-426. PubMed ID: 33031750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
    Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
    Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of EV-A71 neutralizing antibodies following the 2011 epidemic in HCMC, Vietnam.
    Kuo FL; Khanh TH; Chung WY; Hung NT; Luo ST; Chang WC; Nhan LNT; Thinh LQ; Lee MS
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008124. PubMed ID: 32126083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
    Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on epidemiological characteristics of enterovirus 71 cases of hand-foot-mouth disease based on the active monitoring in Guangdong Province in 2011-2015].
    Xie DS; He JF; Yang F; Li H; Kang M; Zhang M; Ye X; Tan XH; Ni XH; Hu L; Sun LM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):738-742. PubMed ID: 29996302
    [No Abstract]   [Full Text] [Related]  

  • 8. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
    Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
    PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
    You L; Chen J; Cheng Y; Li Y; Chen YQ; Ying T; Turtle L; Yu H
    PLoS Pathog; 2023 Jun; 19(6):e1011420. PubMed ID: 37262073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
    Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C
    Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of different specimens in detecting enterovirus A71 in children with hand, foot and mouth disease.
    Zhou Y; Zhou C; Wang K; Qiu Q; Cheng Y; Li Y; Cui P; Liang L; Li P; Deng X; Wang L; Zheng W; Gong H; Wang F; Xu M; Chu JJH; Turtle L; Yu H
    Virol Sin; 2023 Apr; 38(2):268-275. PubMed ID: 36371008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the diagnostic performance and its associated factors of a commercial anti-EV-A71 IgM-capture ELISA kit in hospitalized children with clinical diagnostic HFMD.
    Zhang T; Cheng Y; Li Y; Yang J; Liang L; Yang J; Cui P; Song C; Zhou Y; Kang D; Qiu Q; Cui N; Guo C; Jing Y; Zeng M; Liu Q; Long L; Zhou C; Yu H
    J Clin Virol; 2020 Sep; 130():104582. PubMed ID: 32795960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
    Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
    BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses].
    Cui P; Li Y; Zhou CC; Zhou YH; Song CL; Qiu Q; Wang F; Guo C; Han SJ; Liang L; Yuan Y; Zeng MY; Yue J; Long L; Qin XH; Li Z; Chen XL; Zou YP; Cheng YB; Yu HJ
    Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):445-451. PubMed ID: 31216802
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutralizing antibody against Enterovirus-A71 in Thai children: A longitudinal study from birth to age 4 years.
    Puenpa J; Chansaenroj J; Auphimai C; Srimuan D; Thatsanathorn T; Poovorawan Y; Wanlapakorn N
    Vaccine; 2020 Nov; 38(48):7638-7644. PubMed ID: 33067033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing Antibodies against Enteroviruses in Patients with Hand, Foot and Mouth Disease.
    Nguyet LA; Thanh TT; Nhan LNT; Hong NTT; Nhu LNT; Van HMT; Ny NTH; Anh NT; Han DDK; Tuan HM; Huy VQ; Viet HL; Cuong HQ; Thao NTT; Viet DC; Khanh TH; Thwaites L; Clapham H; Hung NT; Chau NVV; Thwaites G; Ha DQ; van Doorn HR; Tan LV
    Emerg Infect Dis; 2020 Feb; 26(2):298-306. PubMed ID: 31961293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
    Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
    Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
    Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
    Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission and serotype features of hand foot mouth disease in household contacts in Dong Thap, Vietnam.
    Hoang CQ; Nguyen TTT; Ho NX; Nguyen HD; Nguyen AB; Nguyen THT; Phan HC; Phan LT
    BMC Infect Dis; 2019 Nov; 19(1):933. PubMed ID: 31690269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.